Profitability Of Infused Biologics For Hospitals And Physician Practices: Case Study Of Keytruda.
Physician-administered drugs and biologics account for a growing share of pharmaceutical spending, but they also generate substantial revenues for the hospitals and physician practices that acquire the products at one price and are reimbursed at a higher price. This study analyzed insurer expenditur...
| Publicado en: | Health Affairs Vol. 45; no. 8; pp. 855 - 862 |
|---|---|
| Autores principales: | , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Health Affairs Publishing, LLC
Aug2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |